BeOne Medicines Sets Record Date for 2026 AGM to Define Voting Rights

BeOne Medicines Ltd ( (HK:6160) ) has provided an announcement.

BeOne Medicines has set May 22, 2026, as the record date to determine shareholders entitled to attend and vote at its 2026 annual general meeting, requiring share transfer documents to be lodged with its Hong Kong branch registrar by 4:30 p.m. that day. The move signals routine but important corporate housekeeping for the Swiss-listed biotech on HKEX, ensuring clarity over voting rights ahead of the AGM and reinforcing transparency for investors tracking its governance and strategic decisions.

The company has directed investors to the Hong Kong stock exchange website for full AGM details, including the meeting’s date, time and location, which were published with proxy materials on April 28, 2026. With a board composed largely of independent non-executive directors alongside its executive chairman and a non-executive director, BeOne Medicines highlights a governance structure designed to support regulatory compliance, investor confidence and informed shareholder participation in key corporate resolutions.

The most recent analyst rating on (HK:6160) stock is a Buy with a HK$290.00 price target. To see the full list of analyst forecasts on BeOne Medicines Ltd stock, see the HK:6160 Stock Forecast page.

More about BeOne Medicines Ltd

BeOne Medicines Ltd. is a Switzerland-incorporated biopharmaceutical company listed on the Hong Kong Stock Exchange. The firm operates in the life sciences sector and is governed by a board that includes an executive chairman, a non-executive director and a broad slate of independent non-executive directors, underscoring a strong emphasis on corporate governance and international oversight.

Average Trading Volume: 3,809,861

Technical Sentiment Signal: Buy

Current Market Cap: HK$269B

For a thorough assessment of 6160 stock, go to TipRanks’ Stock Analysis page.